Literature DB >> 30310934

Parallel generation of easily selectable multiple nephronal cell types from human pluripotent stem cells.

Krithika Hariharan1, Harald Stachelscheid1,2, Bella Rossbach1, Su-Jun Oh1, Nancy Mah1, Kai Schmidt-Ott3,4, Andreas Kurtz5, Petra Reinke1,3.   

Abstract

Human pluripotent stem cells (hPSCs) provide a source for the generation of defined kidney cells and renal organoids applicable in regenerative medicine, disease modeling, and drug screening. These applications require the provision of hPSC-derived renal cells by reproducible, scalable, and efficient methods. We established a chemically defined protocol by application of Activin A, BMP4, and Retinoic acid followed by GDNF, which steered hPSCs to the renal lineage and resulted in populations of SIX2+/CITED1+ metanephric mesenchyme- (MM) and of HOXB7+/GRHL2+ ureteric bud (UB)-like cells already by 6 days. Transcriptome analysis corroborated that the PSC-derived cell types at day 8 resemble their renal vesicle and ureteric epithelial counterpart in vivo, forming tubular and glomerular renal cells 6 days later. We demonstrate that starting from hPSCs, our in vitro protocol generates a pool of nephrogenic progenitors at the renal vesicle stage, which can be further directed into specialized nephronal cell types including mesangial-, proximal tubular-, distal tubular, collecting duct epithelial cells, and podocyte precursors after 14 days. This simple and rapid method to produce renal cells from a common precursor pool in 2D culture provides the basis for scaled-up production of tailored renal cell types, which are applicable for drug testing or cell-based regenerative therapies.

Entities:  

Keywords:  Differentiation; HPSCS; Nephron; Renal progenitors; Renal vesicle; Tubules

Mesh:

Substances:

Year:  2018        PMID: 30310934     DOI: 10.1007/s00018-018-2929-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  8 in total

1.  Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies.

Authors:  Bella Rossbach; Krithika Hariharan; Nancy Mah; Su-Jun Oh; Hans-Dieter Volk; Petra Reinke; Andreas Kurtz
Journal:  Cells       Date:  2022-04-13       Impact factor: 7.666

2.  Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome.

Authors:  Julia Flemming; Maike Marczenke; Ina-Maria Rudolph; Rikke Nielsen; Tina Storm; Ilsoe Christensen Erik; Sebastian Diecke; Francesco Emma; Thomas E Willnow
Journal:  Kidney Int       Date:  2020-03-24       Impact factor: 10.612

Review 3.  Kidney organoids: accurate models or fortunate accidents.

Authors:  Melissa H Little; Alexander N Combes
Journal:  Genes Dev       Date:  2019-10-01       Impact factor: 11.361

Review 4.  The Utility of Human Kidney Organoids in Modeling Kidney Disease.

Authors:  Aneta Przepiorski; Amanda E Crunk; Eugenel B Espiritu; Neil A Hukriede; Alan J Davidson
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

Review 5.  Regenerative medicine therapies: lessons from the kidney.

Authors:  Jamie A Davies; Patricia Murray; Bettina Wilm
Journal:  Curr Opin Physiol       Date:  2020-04

6.  The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells.

Authors:  Md Shaifur Rahman; Wasco Wruck; Lucas-Sebastian Spitzhorn; Lisa Nguyen; Martina Bohndorf; Soraia Martins; Fatima Asar; Audrey Ncube; Lars Erichsen; Nina Graffmann; James Adjaye
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

7.  Bioengineered Kidney Models: Methods and Functional Assessments.

Authors:  Astia Rizki-Safitri; Tamara Traitteur; Ryuji Morizane
Journal:  Function (Oxf)       Date:  2021-05-10

8.  Functional differentiation and scalable production of renal proximal tubular epithelial cells from human pluripotent stem cells in a dynamic culture system.

Authors:  Thao Thi Thanh Ngo; Bella Rossbach; Isabelle Sébastien; Julia C Neubauer; Andreas Kurtz; Krithika Hariharan
Journal:  Cell Prolif       Date:  2022-01-31       Impact factor: 6.831

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.